BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Genetown

  Industry Visionaries Provide Fresh Perspectives at IBC Life Sciences’s 2012 BioProcess International Conference & Exhibition

  June 4, 2012

   · 

  2 min read
• Drug Development

  Exelixis, Inc. Release: Cabozantinib Demonstrates Evidence of Anti-tumor Effects in Heavily Pretreated Patients With Hepatocellular Carcinoma

  June 4, 2012

   · 

  4 min read
• Drug Development

  Tekmira Pharmaceuticals Corporation’s LNP Technology Enables ALN-VSP Clinical Data

  June 4, 2012

   · 

  1 min read
• Drug Development

  NewLink Genetics Reports Two- and Three-Year Overall Survival Data From Its Phase-2 HyperAcute(R) Pancreas (algenpantucel-L) Immunotherapy Trial at the American Society of Clinical Oncology Annual Meeting

  June 4, 2012

   · 

  1 min read
• China Nuokang Bio-Pharmaceutical Inc. Appoints Lazard and Houlihan Lokey as Independent Financial Advisors to Evaluate “Going Private” Proposal

  June 4, 2012

   · 

  1 min read
• Drug Development

  Canbas Co., Ltd.: CBP501 Met Primary Endpoint of Phase II Study in Malignant Pleural Mesothelioma

  June 4, 2012

   · 

  4 min read
• Pharm Country

  Amarin Corporation PLC Release: AMR101 Phase 3 Study Data in Patients With Diabetes Mellitus (Type 2) to be Presented at the American Diabetes Association’s 72nd Scientific Sessions

  June 4, 2012

   · 

  1 min read
• Drug Development

  PolyMedix Inc. Release: New Data on PMX-30063 Presented at American Society of Clinical Oncology Suggest Strong Potential as Treatment for Oral Mucositis

  June 4, 2012

   · 

  1 min read
• BioMidwest

  Cardinal Health, Inc. to Manufacture, Distribute Eli Lilly and Company’s Brain Imaging Agent Amyvid(TM) (Florbetapir F 18 Injection)

  June 4, 2012

   · 

  7 min read
• Pharm Country

  BioBehavioral Diagnostics Reels in $5.2 Million in Stock Sale

  June 4, 2012

   · 

  1 min read